ID

24892

Description

Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease

Keywords

Versions (2)
  1. 8/22/17 8/22/17 -
  2. 9/4/17 9/4/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

August 22, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

study medication administration determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

English

study medication administration determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

1 forms  
Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
Patient Initials
Description

patient's initials

Data type

text

Alias
UMLS CUI [1]
C2986440
Patient No.
Description

patient number

Data type

integer

Alias
UMLS CUI [1]
C1830427
Dose#1
Description

Dose#1

Alias
UMLS CUI-1
C3174092
Date of Administration
Description

date of administration

Data type

date

Alias
UMLS CUI [1,1]
C1533734
UMLS CUI [1,2]
C0011008
Time of Administration
Description

24-hour clock

Data type

time

Alias
UMLS CUI [1]
C1317775
Dose#2
Description

Dose#2

Alias
UMLS CUI-1
C3174092
Time of Administration
Description

24-hour clock

Data type

time

Alias
UMLS CUI [1]
C1317775
Dose#3
Description

Dose#3

Alias
UMLS CUI-1
C3174092
Time of Administration
Description

24-hour clock

Data type

time

Alias
UMLS CUI [1]
C1317775
Back to the top of the page

Similar models

study medication administration determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
patient's initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
patient number
Item
Patient No.
integer
C1830427 (UMLS CUI [1])
Item Group
Dose#1
C3174092 (UMLS CUI-1)
date of administration
Item
Date of Administration
date
C1533734 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
time of administration
Item
Time of Administration
time
C1317775 (UMLS CUI [1])
Item Group
Dose#2
C3174092 (UMLS CUI-1)
time of administration
Item
Time of Administration
time
C1317775 (UMLS CUI [1])
Item Group
Dose#3
C3174092 (UMLS CUI-1)
time of administration
Item
Time of Administration
time
C1317775 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial